Day

June 12, 2015
Paris, France, 12 June 2015—HiFiBiO will present its novel, integrated platform for the discovery of differentiated therapeutic antibodies at the Next Generation Antibodies and Protein Analysis Conference: Tools and Technologies, on 15 June 2015, in Ghent, Belgium. In a presentation, “Deep Mining of Immune Repertoires”, HiFiBiO’s Chief Scientific Officer, Allan Jensen, PhD, will describe the company’s...
Read More
Exploring New Antibody Discovery Platforms – While current antibody discovery technologies, such as hybridomas, are highly reliable, they are also inefficient in terms of percentage of antigen-specific B cells identified during screening. HiFiBiO and Janssen Biotech, Inc. are collaborating to evaluate the company’s single cell technology for genetically characterizing individual cells as a potential new...
Read More